An improved approach to gene therapy may one day treat some of the nearly 200 inherited forms of blindness, scientists at Washington University School of Medicine in St. Louis suggest this week.
In a paper published online by Public Library of Science ONE, researchers take initial steps toward filling a gap in the toolkit for treating blindness by identifying DNA elements that control when and where genes linked to blindness are turned on.
Three Boston University biomedical engineers have created a genetic dimmer switch that can be used to turn on, shut off, or partially activate a gene’s function. Professor James Collins, Professor Charles Cantor and doctoral candidate Tara Deans invented the switch, which can be tuned to produce large or small quantities of protein, or none at all.
The research detailing their new switch, “A Tunable Genetic Switch Based on RNAi and Repressor Proteins for Regulating Gene Expression in Mammalian Cells,” appears in the July 27 issue of Cell.
One potent, immune-based treatment for cancer is total body irradiation (TBI). This approach first depletes the body of the population of immune cells known as lymphocytes and then involves the adoptive transfer of tumor-specific T cells to the patient. Lymphodepletion has previously been shown to improve the ability of tumor-specific T cells to cause tumor regression.
MicroRNAs became the stars of the RNA universe when, in 2001, scientists found that these short RNAs can control whether or not genes are expressed. This month, scientists at Rockefeller University and the Wellcome Trust cast new light on the genesis of these key biological regulators and how they carry out their function. These provocative new findings were reported online July 12 in the journal Genes & Development.
A class of drugs commonly used to treat type 2 diabetes may double the risk of heart failure, according to a new analysis by researchers at Wake Forest University School of Medicine and colleagues.
GPs are still prescribing antibiotics for up to 80% of cases of sore throat, otitis media, upper respiratory tract infections, and sinusitis, despite the fact that official guidance warns against this practice, according to an analysis1 of the world’s largest primary care database of consultations and prescriptions, published this week in a supplement2 to the Journal of Antimicrobial Chemotherapy.
A new University of Georgia study finds that sewage-contaminated groundwater is reaching the offshore reefs of the Upper Florida Keys, possibly threatening corals and human health.
Studies in mice suggest that a red blood cell substitute based on human hemoglobin could be a promising new treatment for sickle cell disease in humans.
Millions of Americans take statins to lower their cholesterol, but how low should you go" Many scientific studies support the benefits of lowering low-density lipoprotein (LDL) cholesterol, and achieving low LDL cholesterol levels is one of the most important steps in preventing heart disease. New research, however, provides evidence for an association between low LDL levels and cancer risk.
Cancer patients don’t have time to waste. Many go through several different treatments, however, to find one that is more effective against their particular type of tumor.
Dan Theodorescu, M.D., Ph.D., a University of Virginia oncologist and cancer biologist, and Jae Lee, Ph.D., a computational biologist and bioinformatics statistician, have pioneered a system that matches the tumor to the best known treatment.
Iron is the workhorse of trace minerals. An essential component of red blood cells, disruption of iron levels in the body will result in a myriad of serious conditions, and life cannot be sustained without it.
In novel research, investigators at the University at Buffalo’s School of Public Health and Health Professions, have learned that iron is only one half of an all-important duo of trace minerals -- the other being copper -- that work in tandem to maintain proper iron balance, or homeostasis. It appears the workhorse has a helper.
Studying chimpanzees trained to use treadmills, a team of anthropologists has gathered new evidence suggesting our earliest apelike ancestors started walking on two legs because it required less energy than getting around on all fours.
A chimpanzee walks upright on a treadmill as part of UC Davis anthropologist Michael Sockol's research into the origins of bipedalism. The face mask helps scientists measure oxygen consumption. Credit: Copyright Cary Wolinsky
USC structural biologists reveal workings of nicotine receptor in 'landmark accomplishment.'
When nicotine binds to a neuron, how does the cell know to send the signal that announces a smoker’s high?
As with other questions involving good sensations, the answer appears to be sugar.
A University of Southern California study appearing with a commentary in Nature Neuroscience online proposes a role for sugar as the hinge that opens a gate in the cell membrane and brings news of nicotine’s arrival.
The adverse effects of using prescription drugs side by side with natural health products (NHP) are being under-reported, so the potential risks may be underestimated by health-care professionals and the public, a study from the University of Alberta in Edmonton, Canada shows.
Individuals who receive blood transfusions from donors with undiagnosed cancers are at no higher risk of developing malignant disease than people who receive blood from donors without cancer, according to the results of a retrospective study published in The Lancet last month.